Clinical Trials on Philadelphia Positive in Germany
Total 299 results
-
Astellas Pharma Europe Ltd.Cubist Pharmaceuticals LLCTerminatedClostridium DifficileSpain, France, Germany, Greece, Denmark, Austria, Poland
-
Foundation for Innovative New Diagnostics, SwitzerlandCompletedTuberculosis | Drug-resistant TuberculosisGeorgia, Germany, India, Moldova, Republic of, South Africa
-
German Breast GroupNovartisCompletedBreast Cancer | Hormone Receptor Positive TumorGermany
-
Institut fuer FrauengesundheitSamsung Bioepis Co., Ltd.RecruitingBreast Cancer | Breast Neoplasms | HER2-positive Breast Cancer | Breast Cancer FemaleGermany
-
European Society for Blood and Marrow TransplantationBristol-Myers SquibbTerminatedChronic Myeloid LeukemiaSwitzerland, United Kingdom, France, Germany
-
Aesculap AGCompletedKidney Cancer | Nephrolithiasis | Prostate Cancer | Nephritis | Kidney Injury | Hydronephrosis | Congenital Abnormality of Kidney | Kidney TuberculosisGermany
-
German Breast GroupRoche Pharma AG; Celgene CorporationCompletedInflammatory Breast Cancer | HER-2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage III | Inflammatory Breast Cancer Stage IVGermany
-
Jena University HospitalUniversity of Leipzig; Technische Universität Dresden; University of Magdeburg; University of Rostock and other collaboratorsCompletedHIV Seropositivity | CD4+ T LymphocytopeniaGermany
-
Novartis PharmaceuticalsTerminatedChronic Myeloid Leukemia in Chronic PhaseBelgium, Germany
-
German Breast GroupRoche Pharma AG; Amgen; Teva Pharmaceuticals USA; Vifor PharmaCompletedInflammatory Breast Cancer | HER2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage IIIGermany
-
3MCompletedStaphylococcus AureusUnited States, France, Germany, Netherlands
-
Eli Lilly and CompanyCompletedHER-2 Positive Breast Cancer | Hormone Receptor Positive Breast CancerSpain, United States, Korea, Republic of, Belgium, France, Germany, Italy, Australia, Argentina, Canada, United Kingdom, Mexico, Brazil, Greece
-
University of CologneUnknownClostridium Difficile Infection | Clostridium Difficile DiarrheaGermany
-
Alliance Foundation Trials, LLC.Pfizer; Syneos Health; UNICANCER; German Breast Group; SOLTI Breast Cancer Research... and other collaboratorsActive, not recruitingHER-2 Positive Breast Cancer | Estrogen Receptor Positive Breast CancerUnited States, Spain, France, Italy, Germany, Australia, Portugal, New Zealand
-
GlaxoSmithKlineCompletedInfections, StreptococcalGermany
-
Prof. Dr. Nikolas von BubnoffNovartisTerminated
-
University of Erlangen-Nürnberg Medical SchoolGerman Research Foundation; University Hospital, Essen; Wuerzburg University... and other collaboratorsUnknownAcute Myeloid Leukemia | Multiple Myeloma | Acute Lymphoblastic Leukemia | Chronic Myeloid Leukemia | Myelodysplastic Syndrome | Aplastic Anemia | Non Hodgkin's Lymphoma | Hodgkin's DiseaseGermany
-
Incyte Biosciences International SàrlWithdrawnBCR-ABL Positive Acute Lymphoblastic LeukemiaGermany, France, Czechia
-
Goethe UniversityCompletedSevere Acute Respiratory Syndrome Coronavirus 2 | Prone Position | Pulmonary Ventilation | Hypnotics and SedativesGermany
-
CinnagenCompletedHER2-positive Breast CancerIran, Islamic Republic of
-
Novartis PharmaceuticalsCompletedAdvanced HER2-positive Breast CancerFrance, Italy, Germany, Singapore, Sweden, Spain, United Kingdom, United States
-
Kerman University of Medical SciencesTerminatedChronic Myelogenous LeukemiaIran, Islamic Republic of
-
MJM BontenUniversiteit Antwerpen; Universitätsklinikum Köln; Da VolterraCompletedClostridium DifficileGermany, Spain, France, Greece, Netherlands, Romania
-
AmgenRecruitingNewly Diagnosed Philadelphia (Ph)-Negative B-cell Precursor Acute Lymphoblastic Leukemia (ALL)Japan, Australia, Denmark, Netherlands, Taiwan, Switzerland, Canada, France, United States, Austria, Italy, Spain, Sweden, Belgium, Hungary, Finland, Greece, Turkey, Korea, Republic of, Romania, Portugal, Germany, Bulgaria, Mexico, United...
-
GWT-TUD GmbHIncyte Biosciences International SàrlTerminated
-
Cancer Trials IrelandCompletedLeukemiaUnited States, Ireland, Israel, Germany
-
Sponsor GmbHGlaxoSmithKline; iOMEDICO AG; Arbeitsgemeinschaft fur Internistische Onkologie; Arbeitskreis Klinische StudienTerminatedMetastatic Breast Cancer | HER2 Positive | First or Second Line Therapy | Failure or Contraindication of Trastuzumab TherapyGermany
-
Heinrich-Heine University, DuesseldorfGerman Research FoundationCompletedStaphylococcus Aureus InfectionFrance, Germany, Netherlands, Spain, United Kingdom
-
Research Center BorstelLudwig-Maximilians - University of MunichTerminatedBacterial Infections | Tuberculosis, Pulmonary | Tuberculosis, Multidrug-Resistant | Mycobacterial InfectionGermany, Moldova, Republic of, Romania, Ukraine
-
University of CologneTerminatedPulmonary TuberculosisGermany, Bulgaria, Poland
-
GlaxoSmithKlineCompletedStreptococcal InfectionsGermany
-
Novartis PharmaceuticalsCompletedEstrogen Receptor Positive Breast Cancer | Advanced Solid Tumors With an Alteration of the PIK3CA GeneUnited States, Netherlands, Spain, Germany, United Kingdom
-
Da VolterraSyneos HealthCompletedClostridium Difficile InfectionBulgaria, Germany, Romania, Serbia
-
University of JenaNovartis Pharmaceuticals; Ludwig-Maximilians - University of MunichActive, not recruiting
-
University Hospital MuensterUnknownLung Diseases | Cystic Fibrosis | Lung Function Decreased | Staphylococcus Aureus PneumoniaGermany, Austria
-
Tuberculosis Network European TrialsgroupCompletedTuberculosis | Monitoring, ImmunologicDenmark, United Kingdom, Sweden, Australia, Bulgaria, Germany, Greece, Italy, Netherlands, Portugal, Romania, Spain, Switzerland, Turkey
-
Ferrer Internacional S.A.CompletedEfficacy and Safety of Ozenoxacin 1% Cream Versus Placebo in the Treatment of Patients With ImpetigoImpetigoGermany, South Africa
-
German Breast GroupGlaxoSmithKline; Roche Pharma AG; Teva Pharmaceuticals USACompletedInflammatory Breast Cancer | HER-2 Positive Breast Cancer | Tubular Breast Cancer Stage II | Mucinous Breast Cancer Stage II | Breast Cancer Female NOS | Invasive Ductal Breast Cancer | Tubular Breast Cancer Stage III | Inflammatory Breast Cancer Stage IVGermany
-
iOMEDICO AGNovartis PharmaceuticalsCompletedBreast Cancer | Hormone Receptor Positive Tumor | HER 2 Negative Breast CancerGermany
-
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyRecruitingHER2-positive Advanced Gastric Cancer | HER2-positive Gastroesophageal Junction AdenocarcinomaAustria, Belgium, Germany, Italy
-
Merck Sharp & Dohme LLCCompletedPneumococcal InfectionsAustralia, Belgium, Czechia, Estonia, Germany, Greece, Poland, Russian Federation, Spain
-
AmgenTerminatedMyelodysplastic Syndrome | Relapsed/Refractory AML | Minimal Residual Disease Positive AMLUnited States, Canada, Germany, Netherlands
-
University of ColognePfizerCompletedStaphylococcus Aureus | Wound Infection, Surgical | EpidemiologyGermany, Spain, France, Italy, United Kingdom
-
University Hospital, Basel, SwitzerlandETOP IBCSG Partners Foundation; Austrian Breast Cancer Study GroupRecruitingNode-positive Breast CancerGreece, Switzerland, Hungary, Austria, Germany, Italy, Lithuania, Argentina, Croatia
-
University of CologneUnknownStaphylococcus Aureus BacteremiaUnited Kingdom, Spain, Taiwan, Korea, Republic of, Germany
-
ActelionCompletedClostridium Difficile InfectionUnited States, Canada, Germany, Italy, Sweden, United Kingdom
-
GlaxoSmithKlineCompletedInfections, StreptococcalGermany, Czechia, Sweden, Poland
-
Amsterdam UMC, location VUmcOdense University Hospital; Helsinki University Central Hospital; Aarhus University... and other collaboratorsRecruitingCML, RelapsedDenmark, Norway, Sweden, Netherlands, Finland, France, Germany
-
Gruppo Italiano Malattie EMatologiche dell'AdultoCompletedChronic Myeloid LeukemiaIraq, Germany, Austria, Italy, Taiwan, Greece, Netherlands, United States, Belgium, France
-
University of JenaRecruitingChronic Myeloid Leukemia in Myeloid Blast CrisisGermany, Czechia, Russian Federation, Ukraine